References
- Stewardson AJ, Marimuthu K, Sengupta S, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study. Lancet Infect Dis. 2019;19(6):601–610. doi:10.1016/S1473-3099(18)30792-8
- Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis. 2014;20(7):1170–1175. doi:10.3201/eid2007.121004
- McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017;12(10):e0186195. doi:10.1371/journal.pone.0186195
- Bartsch SM, McKinnell JA, Mueller LE, et al. Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States. Clin Microbiol Infect. 2017;23(1):48 e49–48 e16. doi:10.1016/j.cmi.2016.09.003
- Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
- Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy. Front Microbiol. 2019;10:1823. doi:10.3389/fmicb.2019.01823
- Lutgring JD. Carbapenem-resistant Enterobacteriaceae: an emerging bacterial threat. Semin Diagn Pathol. 2019;36(3):182–186. doi:10.1053/j.semdp.2019.04.011
- Malchione MD, Torres LM, Hartley DM, Koch M, Goodman JL. Carbapenem and colistin resistance in Enterobacteriaceae in Southeast Asia: review and mapping of emerging and overlapping challenges. Int J Antimicrob Agents. 2019;54(4):381–399. doi:10.1016/j.ijantimicag.2019.07.019
- Zhang Y, Wang Q, Yin Y, et al. Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE Network. Antimicrob Agents Chemother. 2018;62(2). doi:10.1128/AAC.01882-17
- Wang Q, Wang X, Wang J, et al. Phenotypic and genotypic characterization of carbapenem-resistant Enterobacteriaceae: data from a Longitudinal Large-scale CRE Study in China (2012–2016). Clin Infect Dis. 2018;67(suppl_2):S196–S205. doi:10.1093/cid/ciy660
- Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
- Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing: Thirtieth Informational Supplement. M100-S30. Wayne (PA): The Institute CaLS; 2020.
- Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.002
- Novovic K, Mihajlovic S, Vasiljevic Z, Filipic B, Begovic J, Jovcic B. Carbapenem-resistant Acinetobacter baumannii from Serbia: revision of CarO classification. PLoS One. 2015;10(3):e0122793. doi:10.1371/journal.pone.0122793
- Kontopoulou K, Iosifidis E, Antoniadou E, et al. The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection. J Med Microbiol. 2019;68(3):326–335. doi:10.1099/jmm.0.000921
- Gu JN, Chen L, Weng XB, Yang XY, Pan DM. Clinical and microbiological characteristics of a community-acquired carbapenem-resistant Escherichia coli ST410 isolate harbouring blaNDM-5-encoding IncX3-type plasmid from blood. Front Med. 2021;8:658058. doi:10.3389/fmed.2021.658058
- Tamma PD, Kazmi A, Bergman Y, et al. The likelihood of developing a carbapenem-resistant Enterobacteriaceae infection during a hospital stay. Antimicrob Agents Chemother. 2019;63(8). doi:10.1128/AAC.00757-19
- Roer L, Overballe-Petersen S, Hansen F, et al. Escherichia coli sequence type 410 is causing new international high-risk clones. mSphere. 2018;3(4). doi:10.1128/mSphere.00337-18
- Perez F, Bonomo RA. Carbapenem-resistant Enterobacteriaceae: global action required. Lancet Infect Dis. 2019;19(6):561–562. doi:10.1016/S1473-3099(19)30210-5
- Nadimpalli ML, de Lauzanne A, Phe T, et al. Escherichia coli ST410 among humans and the environment in Southeast Asia. Int J Antimicrob Agents. 2019;54(2):228–232. doi:10.1016/j.ijantimicag.2019.05.024
- Pitout JDD, Peirano G, Kock MM, Strydom KA, Matsumura Y. The global ascendency of OXA-48-type carbapenemases. Clin Microbiol Rev. 2019;33(1). doi:10.1128/CMR.00102-19
- Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27(3):543–574. doi:10.1128/CMR.00125-13
- Roer L, Hansen F, Thomsen MCF, et al. WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. J Antimicrob Chemother. 2017;72(7):1922–1929. doi:10.1093/jac/dkx092
- Nukui Y, Ayibieke A, Taniguchi M, et al. Whole-genome analysis of EC129, an NDM-5-, CTX-M-14-, OXA-10- and MCR-1-co-producing Escherichia coli ST167 strain isolated from Japan. J Glob Antimicrob Resist. 2019;18:148–150. doi:10.1016/j.jgar.2019.07.001
- Zong Z, Fenn S, Connor C, Feng Y, McNally A. Complete genomic characterization of two Escherichia coli lineages responsible for a cluster of carbapenem-resistant infections in a Chinese hospital. J Antimicrob Chemother. 2018;73(9):2340–2346. doi:10.1093/jac/dky210
- Bibbolino G, Di Lella FM, Oliva A, et al. Molecular epidemiology of NDM-5-producing Escherichia coli high-risk clones identified in two Italian hospitals in 2017–2019. Diagn Microbiol Infect Dis. 2021;100(4):115399. doi:10.1016/j.diagmicrobio.2021.115399